The National Alliance for Life Sciences and Health is a thematic research alliance in France created on April 8, 2009, as part of the National Strategy for Research and Innovation (SNRI), which identified health, food, and biotechnology as one of its three priority development areas.
Missions
editAviesan works exclusively in the fields of life sciences and health.
Aviesan's stated objective is "to further enhance the performance of French research by promoting its coherence, creativity and excellence. This mission calls for scientific coordination of major research themes that cut across all organizations, and operational coordination of projects, resources and means".[1]
Achievements
editIn 2009, Aviesan coordinated research to find a vaccine against the H1-N12 virus.[2]
In 2011, Aviesan provides a report and recommendations to the government following the Fukushima nuclear accident.[2]
In 2020, Aviesan coordinates French research to find a vaccine against the COVID-19 coronavirus.[3]
Presidents
editReferences
edit- ^ "Missions & réalisations / aviesan". aviesan.fr. Retrieved 2023-05-11.
- ^ a b "Alliance nationale pour les sciences de la vie et de la santé : 3 ans de réalisations pour une recherche française au meilleur niveau mondial / aviesan". aviesan.fr. Retrieved 2023-05-11.
- ^ Nouvelle, L'Usine (2020-03-11). "La France va entamer un essai clinique sur des traitements existants contre le Covid-19" (in French).
{{cite journal}}: Cite journal requires|journal=(help) - ^ "CORONAVIRUS : la riposte de la recherche". www.larecherche.fr (in French). Retrieved 2023-05-11.
This article needs additional or more specific categories. (May 2023) |